Jackson Acquisition Co II
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Jackson Acquisition Co II
Blank Checks, SIC 6770
Jackson Acquisition Company II is a blank check company established to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company concentrates its acquisition efforts on identifying high-quality target businesses within the healthcare sector, particularly healthcare services and healthcare technology. It does not offer commercial products or services, nor does it have operating business segments or customers, and its primary activity is evaluating potential transaction candidates.
The entity maintains its executive offices in Alpharetta, Georgia, and has its registered office in Grand Cayman, Cayman Islands. Formed as an exempted company to conduct operations outside the Cayman Islands, the organization does not operate physical stores or facilities in other jurisdictions. It was incorporated in 2024 and does not report business operations across international markets.
Summary of the business section of Jackson Acquisition Co II's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Jackson Acquisition Co II
- Founded
- 2024
- Headquarters
- Alpharetta, GA
- Address
- 2655 Northwinds Parkway 30009
- Phone
- (770) 643-5605
- Employees
- 10, Dec 31, 2025
- Industry
- Blank Checks
- Fiscal year ends
- December 31
- Auditor
- WithumSmith+Brown, PC, New York, New York
Stock & identifiers
- Ticker
- JACS
- Other tickers
- JACS.RI, JACS.UN
- Exchange
- NYSE
- IPO date
- Dec 11, 2024
- Shares outstanding
- 30M, Aug 11, 2026
- Public float
- $240.50M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2039058
- CUSIP
- G4992A110
- ISIN
- USG4992A1101
- EIN
- 98-1810786
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Richard Lee Jackson | CEO, Director | – |
| David Lawrence | CFO | – |
| Paul G. Gabos | Director | – |
| James Nicholas Ayers | Director | – |
| Brian Anthony McCarthy | Director | – |
| Stephan Rodgers | Director | – |
Employees
Headcount reported in annual reports
“● our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; … ● the other risk and uncertainties discussed in “Item 1A. Risk Factors,” elsewhere in this Annual Report on Form 10-K and in our other filings with the SEC.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Feb 10, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Dec 11, 2024 | IPO | Initial public offering priced (424B4 prospectus) |
| Dec 5, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |